<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Pharmaceutical and Biomedical Research</title>
<title_fa></title_fa>
<short_title>Pharm Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://pbr.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-4486</journal_id_issn>
<journal_id_issn_online>2423-4494</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/pbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Successful Use of Two Thrombolytic Drugs in Prosthetic Mitral and Aortic Valve Thrombosis</title>
	<subject_fa>داروسازی بالینی</subject_fa>
	<subject>Clinical Pharmacy</subject>
	<content_type_fa>گزارش مورد</content_type_fa>
	<content_type>case report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Prosthetic valve thrombosis is a rare and severe complication of valve replacement, most often encountered with a mechanical prosthesis. The significant morbidity and mortality associated with this condition warrant rapid diagnostic evaluation. Although surgery is the first-line therapy in symptomatic obstructive mechanical valve thrombosis, thrombolytic therapy has been used as an alternative.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Case Description:&lt;/strong&gt; In this case report, we describe a 46-year-old man with a history of the mitral valve and aortic valve replacement 2 years ago. In echocardiography, we detected a mobile mass on the atrial side of the mitral valve prosthesis and a fixed one on the leaflet of the mechanical aortic valve with a high gradient. To save his life, we used double thrombolytic therapy considering the patient&amp;rsquo;s hemodynamic situation and the risk of bleeding. Although a routine dose of reteplase and streptokinase was considered, we administered these two thrombolytic drugs together within 72 hours.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Conclucsion:&lt;/strong&gt; Ultimately we succeeded with this method without any significant or life-threatening adverse effects, and the patient was discharged after an optimal anticoagulation therapy.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Mitral valve, Aortic valve, Thrombolytic, Reteplase, Streptokinase</keyword>
	<start_page>69</start_page>
	<end_page>74</end_page>
	<web_url>http://pbr.mazums.ac.ir/browse.php?a_code=A-10-759-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Shayesteh</first_name>
	<middle_name></middle_name>
	<last_name>Gheibi</last_name>
	<suffix></suffix>
	<first_name_fa>شایسته</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>غیبی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shayestegheybi@yahoo.com</email>
	<code>10031947532846005102</code>
	<orcid>1368-0526-1989-0526</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Pharmacy, Cardiovascular Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Aliasghar</first_name>
	<middle_name></middle_name>
	<last_name>Farsavian</last_name>
	<suffix></suffix>
	<first_name_fa>علی اصغر</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>فرسویان</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dralicardio@yahoo.com</email>
	<code>10031947532846005103</code>
	<orcid>1368-0526-1989-0526</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Cardiology, School of Medicine Cardiovascular, Research Center, Sari Fatemeh Zahra Hospital, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Nabati</last_name>
	<suffix></suffix>
	<first_name_fa>مریم</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>نباتی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr.mr.nabati@gmail.com</email>
	<code>10031947532846005104</code>
	<orcid>1368-0526-1989-0526</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Cardiology, School of Medicine Cardiovascular, Research Center, Sari Fatemeh Zahra Hospital, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Gohar</first_name>
	<middle_name></middle_name>
	<last_name>Eslami</last_name>
	<suffix></suffix>
	<first_name_fa>گوهر</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>اسلامی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr.gohar.eslami@gmail.com</email>
	<code>10031947532846005105</code>
	<orcid>1368-0526-1989-0526</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Clinical Pharmacy, Cardiovascular Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
